DAB2IP is altered in 0.04% of all cancers with anal squamous cell carcinoma, cancer of unknown primary, NOS, invasive breast carcinoma, lung adenocarcinoma, and poorly differentiated non-small cell lung cancer having the greatest prevalence of alterations .
The most common alteration in DAB2IP is DAB2IP-NTRK2 Fusion (0.04%) .
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.